Zoekresultaten - 108 results
Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.
immunogenicity of the most common travellers’ vaccine hepatitis A (HepA) and the pneumococcal conjugate vaccine (PCV) increasingly used both at home and before travel. METHODS: Volunteers aged ≥18 years (n = 305) ...
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
(Spain), and Luxembourg. In persons aged ≥80 years, Belgium and Portugal rolled out the second booster dose over spring 2022 and the third booster dose in autumn 2022, while the administration of a second ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
COVID-19-related death declined over time for both age groups, while the second booster VE against death remained above 80% for the ≥80 years. CONCLUSIONS: Successive vaccine boosters played a relevant role in ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
the Alpha period, VE against hospitalisation with SARS-CoV2 for complete Comirnaty PSV was 85% (95% CI: 69-92) overall and 75% (95% CI: 42-90) in those aged ≥ 80 years. During the Delta period, among ...
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
February 16, 2022) . From May 2022, Flanders offered a second booster vaccination to nursing home (NH) residents and people aged over 80 years. In early July 2022, a second booster vaccination was offered to ...
Post COVID-19 condition and its physical, mental and social implications: protocol of a 2-year longitudinal cohort study in the Belgian adult population.
a longitudinal cohort study organised over a two-years period between April 2021 and April 2023. The eligible population is all people aged 18 years and older, living in Belgium, with a recent COVID-19 infection ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Pierre Hubin; Matthieu Billuart; Achille Djiena; Romain Mahieu; Hammami, Naïma; Dieter Van Cauteren; Chloé Wyndham-Thomas Source: Vaccine, Volume 40, Issue 22 (2022) Keywords: Ad26COVS1 Aged Aged, 80 and ...
Post COVID-19 condition and its physical, mental and social implications: protocol of a 2-year longitudinal cohort study in the Belgian adult population
Ridder; Rana Charafeddine Source: Archives of Public Health, Volume 80, Issue 1 (2022) Keywords: COVID-19 health longitudinal study Post COVID-19 condition Symptoms Abstract: Background: Since the onset of ...
Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium
Marie Source: Eur J Clin Microbiol Infect Dis, Volume 40, Issue 11 (2021) Keywords: ADOLESCENT Adult Aged Aged, 80 and over Anti-Bacterial Agents Belgium Child Child, Preschool Female Genome, Bacterial ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
Madhavan Radhakrishna; Radhakrishna, Madhavan; Bogers, Johannes; Pawlita, Michael; Tommasino, Massimo; M. Arbyn; HPV-AHEAD study group Source: Cancer Epidemioly, Volume 72 (2021) Keywords: Adult Aged Aged, ...